UV light can kill Covid without harming human : American Journal of Infection control

▴ uv-light-can-kill-covid-american-journal-of-infection-control
The journal proves what doctors/pathologists believed for long time

A new study has found that a form of ultraviolet radiation can effectively destroy SARS-CoV-2, the virus causing COVID-19.

This research was published in the American Journal of Infection Control. It provides the first evidence that Ultraviolet C (UVC) light with a wavelength of 222 nanometers (nm) kills the SARS-CoV-2 virus effectively and does not penetrate the human skin.

The UV light of wavelengths between 200 and 280 nm is called Ultraviolet C light. The Hiroshima University researchers who have published their study in the American Journal of Infection Control said that Using 222 nm UVC light is completely safe for humans.

Recent studies have shown that 222 nm UVC is less harmful than 254 nm UVC because UVC (222nm) light has a very minimal skin or eye penetration and is also an important anti-microbial technology.

As the researchers' in vitro experiment revealed, after a 30-second exposure to 222 nm UVC irradiation, 99.7 percent of the SARS-CoV-2 viral culture was destroyed. Experiments were performed using a UVC lamp, . A virus-containing solution was spread onto a tray. Before positioning the UVC lamp 24 cm above the surface of the plates, researchers allowed it to dry out.

A wavelength of 222 nm UVC can not penetrate the human eye and skin's outer layer, so it won't damage the cells beneath. But, 254 nm UVC germicidal lamps damage human tissues that are exposed, and can only be used to sanitise empty spaces.

The researchers said that "We did not evaluate this technology in a real-world setting, such as a surface counter-top." They suggested further evaluation of the safety and efficacy of 222 nm UVC irradiation in the real-world surface killing of SARS-CoV-2 viruses.

Tags : #UVlightkillsCovid #AmericanJournalOfInfectionControl #LatestCovidNewsSep19 #HiroshimaUniversity #Invitro #LatestCovidClinicalResearchSep19 #WhatKillsCovid

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024